MAPS colleague Jose Carlos Bouso, Ph.D. Candidate, previous principal investigator of an MDMA/PTSD study in Spain, did not receive a 200,000 Euro government grant he had applied for last year. Jose had …
Several templates for our planned study of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD) have been submitted for review to Clinquest JO, a Jordanian Clinical Research …
Unfortunately, a several hundred thousand euro grant that MAPS colleague and Spanish Researcher Jose Carlos Bouso, Ph.D. Candidate applied for to conduct an MDMA/PTSD study in Spain was rejected. MAPS …
Our study in Jordan is able to move another step forward now that we have reached an agreement with a Jordanian insurance agency. Now that the study is insured we can submit the protocol to the Jordanian …
After over a year of planning and preparations to conduct an MDMA/PTSD study in Vancouver, Health Canada placed a major hurdle on the study. For the past several months, we have been under the impression …
MAPS has partnered with a few Canadian Citizens to create MAPS Canada an official Canadian non-profit and sister organization to MAPS. MAPS Canada is being created to allow Canadian Citizens to make tax-deductible …
We had an exciting fundraiser in Vancouver, British Colombia, Canada, where we raised over $10,000 for our planned Canadian MDMA/PTSD study. The benefit dinner was attended by several prominent figures …
On September 30, we submitted our draft protocol, informed consent, and Case Report Forms for our Jordanian MDMA/PTSD research to Principal Investigator Nasser Shuriquie, M.D. and his Jordanian research …
We are in the final stages of getting our Canadian MDMA/PTSD study up and running. At the beginning of this month, Colin Holyk from Kerrisdale Pharmacy went to the Royal Canadian Mounted Police (RCMP) …
MAPS Executive Director Rick Doblin Ph.D. visited Amman, Jordan to further explore MAPS planned Jordanian MDMA/PTSD study. Principal Investigator Dr. Nasser Shuriquie, who had been working for the Royal …
IRB Services, the Canadian IRB that we are working with, has approved the changes to our MDMA/PTSD protocol that were made by Health Canada. MAPS Canadian MDMA-assisted psychotherapy PTSD study is now …
On March 17, Health Canada issued a No Objection Letter for MAPS’ Canadian MDMA/PTSD study. This means that the Canadian protocol and the MDMA that will be used in that study (from Switzerland) have …
